4200 patienter i kliniske undersøgelser i op til 12 ugers varighed med placebo og aktiv kontrol.
Celecoxib was evaluated for the treatment of the inflammation and pain of OA of the knee and hip in approximately 4200 patients in placebo and active controlled trials of up to 12 weeks duration.